An Bioequivalence Study Of Xanax Extended Release Tablets From Two Different Manufacturing Sites
Clinical trial NCT01330472 · COMPLETED
Trial details
- NCT number
- NCT01330472
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2011-06-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.